Jeffrey H. Cooper, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 14,500 shares at $18.00 ($261K) on 2006-12-06, disclosed to the SEC on 2006-12-08.
Scheduled sale ($261k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BMRN | SELL | 2012-01-05 | $87K | — | Filing → |
| BMRN | SELL | 2011-11-03 | $83K | — | Filing → |
| BMRN | SELL | 2011-10-11 | $625K | — | Filing → |